This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 consolidated revenue up 51 percent to Rs 2,714 million, profit after tax Rs 219 million
CAPILLARY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.7 pts less than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated Q2 FY27 (quarter ended 30 Sep 2026): revenue from operations up 51 percent to Rs 2,713.55 million from Rs 1,793.25 million a year earlier; profit after tax Rs 219.16 million versus Rs 2.88 million. Standalone quarter: revenue Rs 842.58 million versus Rs 465.32 million; profit after tax Rs 294.31 million versus a Rs 29.65 million loss. Standalone half-year operating cash flow: negative Rs 454.50 million.
Strong Q2 sales and profit turnaround should support the stock, but negative half-year operating cash flow and rising receivables are concerns.
| Q2 FY27 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹271.4 Cr | — | — |
| Operating profit | ₹13.88 Cr | — | — |
| Profit after tax | ₹21.92 Cr | — | — |
| EBITDA margin | 14.6% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.